Physician profile
William Smith
NPI 1790079325
$34,200.12
in general payments reported to CMS, 2019-2025
37 companies · $5,697 in 2025
The $5,697 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,764 · 2020: $1,488 · 2021: $1,291 · 2022: $2,291 · 2023: $20K · 2024: $1,679 · 2025: $5,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $4,376 · Travel and Lodging: $4,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,793.75 |
| Food and Beverage | $4,375.55 |
| Travel and Lodging | $4,197.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,718.88 | 2021-2025 | Corevalve Evolut R, Avalus, Penditure |
| Edwards Lifesciences Corporation | $3,692.96 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Atricure, INC. | $2,435.04 | 2019-2023 | |
| Endologix LLC | $1,364.60 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Abiomed | $1,321.71 | 2019-2025 | Impella |
| Baxter Healthcare | $342.13 | 2021-2024 | Preveleak, Floseal |
| Clearflow INC. | $278.63 | 2019 | |
| Artivion, INC. | $242.66 | 2025 | Amds-Ascyrus Medical |
| Boston Scientific Corporation | $241.88 | 2020-2025 | Watchman Flx |
| W. L. Gore & Associates, INC. | $212.37 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Zimmer Biomet Holdings, INC. | $160.61 | 2019-2022 | |
| Medtronic Vascular, INC. | $126.40 | 2020 | |
| Davol INC. | $126.26 | 2021-2023 | Progel Applicator Spray Tips |
| Livanova USA, INC. | $112.52 | 2019-2023 | Tandemlife |
| Bard Access Systems, INC. | $111.07 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $106.58 | 2024 | N/A |
| Kls-Martin L.P. | $70.89 | 2022-2023 | |
| Corcym INC | $60.99 | 2022-2024 | Perceval |
| Csl Behring | $51.49 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.90 | 2024 | Lifevest |
| Werfen USA LLC | $35.74 | 2021-2023 | |
| Chiesi USA, INC. | $33.31 | 2020-2021 | |
| Stryker Corporation | $29.66 | 2023 | Spy-Phi System |
| Advanced Respiratory, INC | $26.39 | 2019 | |
| Ambu INC. | $26.23 | 2023 | |
| Intuitive Surgical, INC. | $25.90 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.16 | 2024 | |
| La Jolla Pharmaceutical Company | $24.92 | 2025 | Giapreza |
| Biom'Up France Sas | $23.54 | 2020 | |
| Silk Road Medical, INC. | $22.98 | 2021 | |
| Trevena, INC. | $19.15 | 2021 | |
| Pfizer INC. | $17.52 | 2024 | |
| Next Science LLC | $15.29 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.04 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $14.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.80 | 2025 | Jardiance |
| Integra Lifesciences Corporation | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.